19 June 2013
Keywords: ShangPharma, Pilot plant facility, Outsourcing, Research, CGPM
Article | 17 January 2011
ShangPharma Corp (NYSE: SHP), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, says it has commenced operations ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.